Kuti, Joseph L.; Kotapati, Srividya; Williams, Peter; … - In: PharmacoEconomics 22 (2004) 5, pp. 301-310
Background: Potential differences in toxicity, potency and acquisition price among the liposomal amphotericin B formulations makes it unclear which agent is less costly when total resource consumption and treatment-associated costs are considered. Design: A retrospective cost-minimisation...